




Healthcare Industry News: Diamics
News Release - January 8, 2007
Maureen Mende Joins Diamics as Director of Regulatory Affairs and Quality Assurance
NOVATO, Calif.--(HSMN NewsFeed)--Diamics, Inc., a San Francisco Bay-area, medical device and diagnostics company, announced today it has appointed Maureen Mende as Director of Regulatory Affairs and Quality Assurance.Prior to joining Dade Behring, Mende served as a pharmaceutical industry consultant assisting with GMP compliance and process/equipment validation support, as well as performing chemical, microbiological and environmental testing for Abbott Laboratories.
"Maureen Mende brings broad regulatory and quality experience to Diamics, including FDA and International Product Submissions and Registrations," said Christine Meda, President, Diamics, Inc. "She will be a critical asset to our team as we move our proprietary technology forward to develop viable cancer screening and diagnostic systems."
Mende holds a B.S. degree from Aurora University, Aurora Illinois, and an MBA from Golden Gate University, Sacramento. She has been RAC certified since 1999 and is an ISO trained Lead Auditor.
About Diamics, Inc.
Diamics Inc. is a privately owned medical device and diagnostics company located in Novato, Calif. The company is committed to developing, manufacturing and marketing cost-effective, molecular-based cancer screening and diagnostic systems that will increase long-term survival rates through early detection. Diamics has a mature management team with an extensive track record in the medical device and diagnostics industries. The company's goals are to help medical personnel worldwide improve lives and to create value for investors, employees and all who use and benefit from its proprietary technology. Please visit www.Diamics.com.
Source: Diamics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.